Etiology


  • Risk factors for asthma include:
    • Family history of asthma
    • Past history of allergies
    • Atopic dermatitis
    • Low socioeconomic status
  • Allergic asthma (extrinsic asthma) vs Nonallergic asthma (intrinsic asthma)
    • Allergic asthma (extrinsic asthma)
      • Cardinal risk factor: atopy
      • Environmental allergens: pollen (seasonal), dust mites, domestic animals, mold spores
      • Allergic occupational asthma from exposure to allergens in the workplace (e.g., flour dust)
    • Nonallergic asthma (intrinsic asthma)
      • Viral respiratory tract infections (one of the most common stimuli, especially in children)
      • Cold air
      • Physical exertion (laughter, exercise-induced asthma)
      • Gastroesophageal reflux disease (GERD): often exists concurrently with asthma
      • Chronic sinusitis or rhinitis
      • Medication: aspirin/NSAIDS (aspirin-induced asthma), beta blockers
      • Stress
      • Irritant-induced occupational asthma (e.g., from exposure to solvents, ozone, tobacco or wood smoke, cleaning agents)

Tip

  • Allergic asthma (extrinsic asthma): A type of asthma triggered by allergens (e.g., pollen, dust mites, mold spores, pet allergens). Typically onset in childhood.
  • Nonallergic asthma (intrinsic asthma): A type of asthma that typically develops in patients > 40 years of age.

Pathophysiology


Common underlying pathophysiology

L41542.jpg Asthma is an inflammatory disease driven by T-helper type 2 cells (Th2-cell) that manifests in individuals with a genetic predisposition. It consists of the following three pathophysiologic processes:

  1. Bronchial hyperresponsiveness
  2. Bronchial inflammation
    • Symptoms are primarily caused by inflammation of the terminal bronchioles, which are lined with smooth muscle but lack the cartilage found in larger airways.
  3. Endobronchial obstruction caused by:
    • Increased parasympathetic tone
      • Reversible bronchospasm
      • Increased mucus production
      • Mucosal edema and leukocyte infiltration into the mucosa with hyperplasia of goblet cells
    • Hypertrophy of smooth muscle cells

Type-specific pathophysiology

  • Allergic asthma
    • IgE-mediated type 1 hypersensitivity to a specific allergen
    • Characterized by mast cell degranulation and release of histamine after a prior phase of sensitization
  • Nonallergic asthma
    • Irritant asthma: irritant enters lung → ↑ release of neutrophils → submucosal edema → airway obstruction
    • Aspirin-induced asthma (NSAID-exacerbated respiratory disease) is characterized by the Samter triad:
      • Inhibition of COX-1 → ↓ PGE2 → ↑ leukotrienes and inflammation → submucosal edema → airway obstruction
      • Chronic rhinosinusitis with nasal polyposis
      • Asthma symptoms

Clinical features


Diagnostics

Spirometry

  • Supportive findings: Expiratory airway limitation: i.e., ↓ FEV1 and ↓ FEV1/FVC ratio
  • Bronchodilator Responsiveness Testing:
    • Used when the patient has abnormal baseline spirometry showing obstruction (FEV1/FVC ≤70%)
    • Tests if the obstruction is reversible (suggesting asthma) or fixed (suggesting conditions like COPD)
    • Not useful if current spirometry is normal, even if the patient has asthma symptoms
    • Quick test: perform spirometry → give bronchodilator → repeat spirometry
  • Bronchial Challenge Testing:
    • Identify airway hyperresponsiveness and bronchoconstriction in response to direct, nonallergic stimuli (e.g., methacholine, histamine) or indirect stimuli (e.g., exercise, hyperventilation).
    • Used when patient has symptoms suggestive of asthma but normal baseline spirometry
    • Tests for airway hyperresponsiveness by attempting to provoke bronchospasm
    • Particularly useful for patients with intermittent symptoms who are asymptomatic during office visits
    • More time-intensive: involves giving increasing doses of the provocative agent and measuring response

Treatment


Pasted image 20250312204728.png

Antileukotrienes

Leukotriene receptor antagonists (LTRAs)

  • Montelukast, Zafirlukast
  • Uses
    • Exercise-induced
    • Prevent leukotrienes from binding to their receptors (CysLT1)→ ↓ bronchoconstriction and inflammation
    • Asthma aspirin-induced asthma
    • Long-term maintenance treatment (particularly in children)

Leukotriene pathway modifiers

  • Zileuton
  • Inhibit 5-lipoxygenase → ↓ production of leukotrienes → ↓ bronchoconstriction and inflammation
  • Uses
    • Exercise-induced asthma
    • Aspirin-induced asthma

Mnemonic

Antileukotrienes Montelukast, zafirlukast, zileuton

Long-acting muscarinic antagonists (LAMA)

  • Tiotropium bromide(噻托溴铵)
  • Long-term maintenance treatment

Mast cell stabilizers (chromones)

  • Cromolyn
  • Inhibit mast cell degranulation and prevent release of preformed chemical mediators.
  • Uses
    • Preventive treatment prior to exercise

Biologics

Anti-IgE antibodies

  • Omalizumab 单抗记忆
  • Binds to serum IgE → ↓ expression of high-affinity IgE receptors (FcεRI) on mast cells and basophils
  • Uses
    • Select cases of severe asthma

IL-5 antibodies

  • mepolizumab, reslizumab,benralizumab
  • Block the effects of IL-5 on eosinophils → ↓ chemotaxis and ↓ cell differentiation, maturation, and activation
  • Uses
    • Refractory severe eosinophilic asthma